Debt Financing

Thermo Fisher Scientific (NYSE: TMO) announced the pricing of a €2.1 billion euro-denominated notes offering via its finance subsidiary. The offering includes €1 billion in floating rate notes due 2027 and €1.1 billion in 3.628% fixed rate notes due 2035, both priced at 100%. Closing is expected around December 1, 2025, subject to conditions. Proceeds are intended for general corporate purposes, including potential acquisitions, debt management, and capital investments.

DigitalOcean priced $550M in convertible senior notes due 2030, up from $500M, in a private offering. They’ll use $73.81M for capped call transactions against dilution and the rest with term loans to repurchase $1,131.3M of existing 2026 notes, extending repayment & potentially benefiting from interest rates. Initial conversion is 25.5317 shares/$1,000 note (39.17/share, 32.5% premium). DOcan redeem notes starting 2028 if share price exceeds 130% conversion price. A new $100M stock repurchase program was also authorized.